Medifast, Inc. Payments to Acquire Debt Securities, Available-for-sale
Medifast, Inc. (MED) reported Payments to Acquire Debt Securities, Available-for-sale of $94.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-03
- Medifast, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $45.46M, a 182.88% increase year-over-year.
- Medifast, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $49.32M, a 229.00% increase year-over-year.
- Medifast, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $32.91M, a 47.96% increase year-over-year.
- Medifast, Inc. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $20.43M, a 204.74% increase year-over-year.
- Medifast, Inc. payments to acquire debt securities, available-for-sale for fiscal 2025 was $84.41M, a 81.15% increase from fiscal 2024.
- Medifast, Inc. payments to acquire debt securities, available-for-sale for fiscal 2024 was $46.59M, a 22.02% decline from fiscal 2023.
- Medifast, Inc. payments to acquire debt securities, available-for-sale for fiscal 2023 was $59.76M.
- Medifast, Inc. payments to acquire debt securities, available-for-sale for fiscal 2022 was $0.00.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month | Payments to Acquire Debt Securities, Available-for-sale 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $45.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $94.78M 10-Q · filed 2026-08-03 | $127.69M derived: sum of 3 quarters · filed 2026-08-03 | $148.13M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2026-03-31 | $49.32M 10-Q · filed 2026-05-04 | $82.23M derived: sum of 2 quarters · filed 2026-05-04 | $102.67M derived: sum of 3 quarters · filed 2026-05-04 | $118.74M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-12-31 | $32.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $53.34M derived: sum of 2 quarters · filed 2026-02-17 | $69.42M derived: sum of 3 quarters · filed 2026-08-03 | $84.41M 10-K · filed 2026-02-17 | |
| 2025-09-30 | $20.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $36.50M derived: sum of 2 quarters · filed 2026-08-03 | $51.49M 10-Q · filed 2025-11-03 | $73.74M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-06-30 | $16.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $31.06M 10-Q · filed 2026-08-03 | $53.31M derived: sum of 3 quarters · filed 2026-08-03 | $60.01M derived: sum of 4 quarters · filed 2026-08-03 | |
| 2025-03-31 | $14.99M 10-Q · filed 2026-05-04 | $37.23M derived: sum of 2 quarters · filed 2026-05-04 | $43.94M derived: sum of 3 quarters · filed 2026-05-04 | $52.42M derived: sum of 4 quarters · filed 2026-05-04 | |
| 2024-12-31 | $22.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $28.95M derived: sum of 2 quarters · filed 2026-02-17 | $37.43M derived: sum of 3 quarters · filed 2026-02-17 | $46.59M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $6.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $15.18M derived: sum of 2 quarters · filed 2025-11-03 | $24.35M 10-Q · filed 2025-11-03 | $39.33M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $8.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $17.65M 10-Q · filed 2025-08-04 | $32.62M derived: sum of 3 quarters · filed 2026-02-17 | $77.40M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-03-31 | $9.17M 10-Q · filed 2025-04-28 | $24.15M derived: sum of 2 quarters · filed 2026-02-17 | $68.92M derived: sum of 3 quarters · filed 2026-02-17 | $68.92M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2023-12-31 | $14.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $59.76M derived: sum of 2 quarters · filed 2026-02-17 | $59.76M derived: sum of 3 quarters · filed 2026-02-17 | $59.76M 10-K · filed 2026-02-17 | $54.56M 10-K · filed 2024-02-20 |
| 2023-09-30 | $44.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $44.78M derived: sum of 2 quarters · filed 2024-11-04 | $44.78M 10-Q · filed 2024-11-04 | $44.78M derived: sum of 4 quarters · filed 2025-02-18 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $0.00 10-Q · filed 2024-08-05 | $0.00 derived: sum of 3 quarters · filed 2025-02-18 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-04-29 | $0.00 derived: sum of 2 quarters · filed 2025-02-18 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $0.00 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-06 | ||||
| 2021-12-31 | $0.00 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COFFEE HOLDING CO INC (JVA) | United States | $0.023B | 4.10 |